Middle East & Africa Patient Monitoring Market by Devices (Multi-parameter Monitors, Neuromonitoring Devices, Hemodynamic Monitoring Devices, Cardiac Monitoring Devices, and Other Types of Devices), Applications (Respiratory, Cardiology, Fatal & Nonfatal, Neurology, and Others), End-users (Hospitals & Clinics, Home Healthcare, and Others), and Geography (Middle East and Africa)–Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031
The Middle East & Africa patient monitoring market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 4.8% during 2023–2031. Growth of the market is attributed to rising burden of chronic diseases, changing lifestyles, and growing geriatric population.
Patient monitoring systems are manufactured to provide services at suitable time and place, allowing data access and data entry by medical personnel at the hospitals and nursing homes. Monitoring healthcare technologies are estimated to generate new industries and applications to deal with healthcare issues in the coming years. Patient monitoring system permits efficient response and patient mobility in emergency situations.
The covid-19 pandemic affected the demand and supply of Middle East & Africa patient monitoring market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Middle East & Africa Patient Monitoring Market Trends, Drivers, Restraints, and Opportunities
-
Growing preference for remote & home monitoring is projected to boost the market in the coming years.
-
Increasing use of portable devices is anticipated to drive the market during the forecast period.
-
High price of products is anticipated to restrict the market growth.
-
Lack of awareness about patient monitoring system is projected to hamper the market expansion.
-
R&D investment and technological advancement in patient monitoring system is projected to create lucrative opportunities for the market players.
Scope of Middle East & Africa Patient Monitoring Market Report
The report on the Middle East & Africa patient monitoring market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Middle East & Africa Patient Monitoring Market–Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016-2021 |
Forecast Period |
2023-2031 |
Segmentation |
Devices (Multi-parameter Monitors, Neuromonitoring Devices, Hemodynamic Monitoring Devices, Cardiac Monitoring Devices, and Other Types of Devices), Applications (Respiratory, Cardiology, Fatal & Nonfatal, Neurology, and Others), End-users (Hospitals & Clinics, Home Healthcare, and Others) |
Geographical Scope |
Middle East and Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players covered in the Report |
Siemens Healthcare GmbH; Medtronic Plc; General Electronic Company (GE Healthcare); Boston Scientific Corp.; Becton, Dickinson & Company; Abbott Laboratories; Johnson & Johnson; Koninklijke Philips NV; Alere; Intouch Technologies Inc.; Nihon Kohden Corp.; and Honeywell International Inc. |
Middle East & Africa Patient Monitoring Market Segment Insights
The hemodynamic monitoring devices segment accounts for key share of the market
Based on devices, the Middle East & Africa patient monitoring market is divided into multi-parameter monitors, neuromonitoring devices, hemodynamic monitoring devices, cardiac monitoring devices, and others. The hemodynamic monitoring devices segment accounts for a key share of the market. Growth of the market is attributed to reduction in readmissions and increasing research into hemodynamics monitoring system. However, the multi-parameter monitors segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing geriatric population and rising prevalence of unhealthy routine.
The respiratory segment accounts for a significant share of the market
Based on applications, the market is categorized into respiratory, cardiology, fatal & nonfatal, neurology, and others. The respiratory segment accounts for a key share of the market. Growth of the market is attributed to technological advancement in handiness of equipment and increasing number of critically ill geriatric cases. However, the cardiology segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rising prevalence of diabetes and increasing demand for home based & non-invasive monitoring systems.
The hospitals & clinics segment accounts for a key share of the market
On the basis of end-users, the Middle East & Africa patient monitoring market is fragmented into hospitals & clinics, home healthcare, and others. The hospitals & clinics segment accounts for a key share of the market. Growth of the market is attributed to penetration of monitoring devices and increasing per capita income. However, the home healthcare segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing availability of trained professionals and increasing funding from private organizations.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Patient Monitoring Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Patient Monitoring Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Patient Monitoring Market - Supply Chain
4.5. Global Patient Monitoring Market Forecast
4.5.1. Patient Monitoring Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Patient Monitoring Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Patient Monitoring Market Absolute $ Opportunity
5. Global Patient Monitoring Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Patient Monitoring Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Patient Monitoring Demand Share Forecast, 2019-2026
6. North America Patient Monitoring Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Patient Monitoring Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Patient Monitoring Demand Share Forecast, 2019-2026
7. Latin America Patient Monitoring Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Patient Monitoring Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Patient Monitoring Demand Share Forecast, 2019-2026
8. Europe Patient Monitoring Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Patient Monitoring Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Patient Monitoring Demand Share Forecast, 2019-2026
9. Asia Pacific Patient Monitoring Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Patient Monitoring Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Patient Monitoring Demand Share Forecast, 2019-2026
10. Middle East & Africa Patient Monitoring Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Patient Monitoring Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Patient Monitoring Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Patient Monitoring Market: Market Share Analysis
11.2. Patient Monitoring Distributors and Customers
11.3. Patient Monitoring Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Siemens Healthcare GmbH
11.4.2. Medtronic Plc
11.4.3. General Electronic Company (GE Healthcare)
11.4.4. Boston Scientific Corp.
11.4.5. Becton, Dickinson & Company
11.4.6. Abbott Laboratories
11.4.7. Johnson & Johnson